Antimicrobial therapy is an important tool in reducing the enormous losses in the poultry industry caused by Escherichia coli infections (colibacillosis). However, resistance to existing antimicrobials is widespread and of concern to poultry veterinarians. Antimicrobial resistance testing of 468 avian E. coli strains isolated in Spain showed very high levels of resistance to trimethoprim-sulfamethoxazole (67%) and the new fluoroquinolones (13 to 24%). As these antimicrobial agents may cause cross-resistance with human enteric pathogens, prudent use of them in veterinary medicine is highly recommended.
Escherichia coli is a major pathogen of worldwide importance in commercially produced poultry, contributing significantly to economic losses in both chickens and turkeys (11) . Colibacillosis begins, in general, with an infection of the upper respiratory tract, followed by septicemia (17) . E. coli is commonly found in the intestinal tracts of animals, but usually only certain pathogenic serotypes that show virulence factors (adhesive ability, aerobactin production, serum resistance, and presence of the ColV plasmid) cause disease conditions (5, 9) . Antimicrobial therapy is an important tool in reducing both the incidence and mortality associated with avian colibacillosis (7, 10, 18) . However, resistance to existing antimicrobials is widespread and of concern to poultry veterinarians (1-4, 10, 12-14) . The fluoroquinolones are a new class of antimicrobials that exhibit excellent activity against gram-negative bacilli (8, 16) , although their use in poultry may be inappropriate because of cross-resistance with fluoroquinolones used for treatment of important human enteric infections (6, 8, 15) . The aim of this study was to evaluate the frequency of resistance to quinolones and other groups of antimicrobial agents in avian E. coli strains.
A total of 301 E. coli strains isolated from clinically affected broiler chickens and 167 strains from healthy controls were collected in numerous commercial hatcheries in the province of Orense (Galicia, Spain) during 1992 and 1993. All strains isolated from diseased chickens came from confirmed cases of colisepticemia in which bacteria were obtained in profuse culture from both heart and liver tissues. Fecal strains were isolated from the cloacal content of healthy chickens. The antimicrobial resistance of the strains to different antibacterial agents was determined by the standard disk diffusion method in Mueller-Hinton agar with disks provided by Difco (Detroit, Mich.) and BioMérieux (Marcy l'Etoile, France).
The resistance frequencies (RF) for each antimicrobial agent tested are shown in Table 1 . These RF are generally high and permit the division of the antibiotics into four groups. The first group includes the antibiotics to which there were very high levels of resistance (RF from 67 to 94%). These are streptomycin, tetracycline, sulfadiazine, and trimethoprim-sulfamethoxazole. The second group includes the antibiotics to which there were medium to high levels of resistance (36 to 46%). These are ampicillin, mezlocillin, piperacillin, nitrofurantoin, nalidixic acid, and pipemidic acid. The third group contains the antibiotics to which there were moderate levels of (10) 41 (14) 14 (8) 55 (12) Tobramycin (10) 23 (8) 6 (4) 29 ( (5) 197 (65) 131 (78) (10) 50 (17) 11 (7) 61 (13) Flumequine (30) 72 (24) 19 (11) 91 (19) Ofloxacin (5) 54 (18) 13 (8) 67 (14) Ciprofloxacin (5) 50 (17) 11 (7) 61 (13) Pefloxacin (5) 84 (28) 27 (16) 111 (24) a Amounts are given in micrograms, except where indicated. b Total incidences of resistance of strains from septicemic (n ϭ 301) and healthy (n ϭ 167) chickens were 2,465 and 1,423, respectively (total for both groups, 3,888). Incidences of resistance per strain were 8.2 and 8.5 for septicemic and healthy groups, respectively (average for both groups, 8.3).
resistance (12 to 26%). These are cephalothin, neomycin, kanamycin, gentamicin, chloramphenicol, and the five fluoroquinolones assayed (norfloxacin, flumequine, ofloxacin, ciprofloxacin, and pefloxacin). The fourth group (IV) contains the antibiotics to which there were low levels of resistance (0 to 6%). These are amoxicillin-clavulanic acid, cefoxitin, cefotaxime, tobramycin, amikacin, colistin, and polymyxin B.
In vitro antimicrobial susceptibility testing of veterinary pathogens can provide valuable guidance to the veterinarian in the choice of appropriate chemotherapy. In vitro antibiotic sensitivity results obtained in our study agreed with several previous reports (1, 2, 4, 10, 14) , which have indicated increasing incidences of antibiotic-resistant E. coli strains isolated from chickens with colibacillosis. However, the high percentage of E. coli strains that were resistant to trimethoprim-sulfamethoxazole (67%) and to the new fluoroquinolones (13 to 24%) in our study was surprising. Similar results were found by Amara et al. (2) in Morocco, although the poultry industry in that African, Mediterranean country is relatively young. Our field observations indicate that the abusive and anarchic use of antibiotics is probably the cause of the high percentages of resistance detected in Spanish avian E. coli strains. Since the use of cotrimoxazole and fluoroquinolones in poultry may cause cross-resistance with human enteric pathogens (especially with Salmonella and Campylobacter spp.), prudent use of these antimicrobial agents in avian species is highly recommended.
